Literature DB >> 17457164

An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus.

Bas P L Wijnhoven1, Khe T C Tran, Adrian Esterman, David I Watson, Hugo W Tilanus.   

Abstract

OBJECTIVE: To evaluate prognostic factors and tumor staging in patients after esophagectomy for cancer. SUMMARY BACKGROUND DATA: Several reports have questioned the appropriateness of the sixth edition of the International Union Against Cancer (UICC) TNM guidelines for staging esophageal cancer. Additional pathologic characteristics, besides the 3 basic facets of anatomic spread (tumor, node, metastases), might also have prognostic value.
METHODS: All patients who underwent resection of the esophagus for carcinoma between January 1995 and March 2003 were extracted from a prospective database. Univariate and multivariate analysis was performed to identify prognostic factors for survival. The goodness of fit and accuracy of 3 staging models (UICC-TNM, Korst classification, Rice classification) predicting survival were assessed.
RESULTS: A total of 292 patients (mean age, 63 years) underwent esophagectomy. The 5-year overall survival rate was 29% (median, 21 months). pT-, pN-, pm-stage, and radicality of the resection were independent prognostic factors. Subdivision of T1 tumors into mucosal and submucosal showed significant differences in 5-year survival between both groups: 90% versus 47%, respectively (P = 0.01). Subdivision of pN-stage into 3 groups based on the number of positive nodes (0, 1-2, and >3 nodes positive) or the lymph node ratio (0, 0.01-0.2, and >0.2) also refined staging (P = 0.001 and P < 0.001, respectively). The current subclassification of M1 (M1a and M1b) is not warranted (P = 0.41). The staging model of Rice was more accurate than the UICC-TNM classification in predicting survival.
CONCLUSION: This study supports the view that the current (6th edition) UICC-TNM staging model for esophageal cancer needs to be revised.

Entities:  

Mesh:

Year:  2007        PMID: 17457164      PMCID: PMC1877056          DOI: 10.1097/01.sla.0000251703.35919.02

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  40 in total

1.  Growth patterns and prognosis of submucosal carcinoma of the esophagus. A pathologic study.

Authors:  S Ohno; M Mori; S Tsutsui; H Matsuura; H Kuwano; K Soejima; K Sugimachi
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

2.  Classification of adenocarcinoma of the oesophagogastric junction.

Authors:  J R Siewert; H J Stein
Journal:  Br J Surg       Date:  1998-11       Impact factor: 6.939

Review 3.  Prognostic factors in esophageal cancer.

Authors:  M G Patti; D Owen
Journal:  Surg Oncol Clin N Am       Date:  1997-07       Impact factor: 3.495

4.  Esophagectomy with or without thoracotomy. Is there any difference?

Authors:  H W Tilanus; W C Hop; B L Langenhorst; J J van Lanschot
Journal:  J Thorac Cardiovasc Surg       Date:  1993-05       Impact factor: 5.209

5.  Proposed revision of the staging classification for esophageal cancer.

Authors:  R J Korst; V W Rusch; E Venkatraman; M S Bains; M E Burt; R J Downey; R J Ginsberg
Journal:  J Thorac Cardiovasc Surg       Date:  1998-03       Impact factor: 5.209

6.  Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus.

Authors:  J D Roder; R Busch; H J Stein; U Fink; J R Siewert
Journal:  Br J Surg       Date:  1994-03       Impact factor: 6.939

7.  An evaluation of neural invasion in esophageal cancer.

Authors:  A Tanaka; E Matsumura; H Yosikawa; T Uchida; N Machidera; R Kubo; K Okuno; K Koh; M Watatani; M Yasutomi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

8.  Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases.

Authors:  F Paraf; J F Fléjou; J P Pignon; F Fékété; F Potet
Journal:  Am J Surg Pathol       Date:  1995-02       Impact factor: 6.394

9.  Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases.

Authors:  J M Streitz; F H Ellis; S P Gibb; K Balogh; E Watkins
Journal:  Ann Surg       Date:  1991-02       Impact factor: 12.969

10.  Prognostic factors of resected adenocarcinoma of the esophagus.

Authors:  A H Hölscher; E Bollschweiler; R Bumm; H Bartels; H Höfler; J R Siewert
Journal:  Surgery       Date:  1995-11       Impact factor: 3.982

View more
  69 in total

1.  Feasibility study of sentinel lymph node biopsy in esophageal cancer with conservative lymphadenectomy.

Authors:  Sarah K Thompson; Dylan Bartholomeusz; Peter G Devitt; Peter J Lamb; Andrew R Ruszkiewicz; Glyn G Jamieson
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

2.  Soft-Tissue Metastases From Esophageal Cancer.

Authors:  Jad M El Abiad; Russell K Hales; Adam S Levin; Carol D Morris
Journal:  J Gastrointest Surg       Date:  2019-02-26       Impact factor: 3.452

3.  Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy.

Authors:  Chikara Kunisaki; Hirochika Makino; Ryo Takagawa; Naoto Yamamoto; Yasuhiko Nagano; Syoichi Fujii; Takashi Kosaka; Hidetaka A Ono; Yuichi Otsuka; Hirotoshi Akiyama; Yasushi Ichikawa; Hiroshi Shimada
Journal:  J Gastrointest Surg       Date:  2007-10-20       Impact factor: 3.452

4.  Risk prediction scores for postoperative mortality after esophagectomy: validation of different models.

Authors:  U Zingg; C Langton; B Addison; B P L Wijnhoven; J Forberger; S K Thompson; A J Esterman; D I Watson
Journal:  J Gastrointest Surg       Date:  2008-12-03       Impact factor: 3.452

5.  Prognostic impact of lymph node involvement and the extent of lymphadenectomy (LAD) in adenocarcinoma of the esophagogastric junction (AEG).

Authors:  Leila Sisic; Susanne Blank; Wilko Weichert; Dirk Jäger; Christoph Springfeld; Marcel Hochreiter; Markus Büchler; Katja Ott
Journal:  Langenbecks Arch Surg       Date:  2013-07-26       Impact factor: 3.445

6.  Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.

Authors:  Chen Wei; Wen-Ying Deng; Ning Li; Wei Shen; Chi Zhang; Jia-Yu Liu; Su-Xia Luo
Journal:  Dig Dis Sci       Date:  2015-05-05       Impact factor: 3.199

Review 7.  Endoscopic options for early stage esophageal cancer.

Authors:  Pari M Shah; Hans Gerdes
Journal:  J Gastrointest Oncol       Date:  2015-02

8.  Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancer.

Authors:  Christopher P Twine; S Ashley Roberts; Wyn G Lewis; B Vicki Dave; Claire E Rawlinson; David Chan; Mark Robinson; Tom D Crosby
Journal:  Surg Endosc       Date:  2010-04       Impact factor: 4.584

9.  Clinical impact of lymphadenectomy extent in resectable esophageal cancer.

Authors:  Roderich E Schwarz; David D Smith
Journal:  J Gastrointest Surg       Date:  2007-09-02       Impact factor: 3.452

10.  Long-term outcomes and prognostic factors for patients with esophageal cancer following radiotherapy.

Authors:  Chuang-Zhen Chen; Jian-Zhou Chen; De-Rui Li; Zhi-Xiong Lin; Ming-Zhen Zhou; Dong-Sheng Li; Zhi-Jian Chen
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.